• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酰基葡萄糖醛酸苷的毒理学潜力及其评估

Toxicological potential of acyl glucuronides and its assessment.

作者信息

Iwamura Atsushi, Nakajima Miki, Oda Shingo, Yokoi Tsuyoshi

机构信息

DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, 2-2-50 Kawagishi, Toda 335-8505, Japan.

Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.

出版信息

Drug Metab Pharmacokinet. 2017 Feb;32(1):2-11. doi: 10.1016/j.dmpk.2016.11.002. Epub 2016 Nov 23.

DOI:10.1016/j.dmpk.2016.11.002
PMID:28017536
Abstract

Idiosyncratic drug toxicity (IDT) is a serious problem in drug development. Reactive metabolites are postulated to be one of the causes for IDT. Conjugated metabolites are generally non-reactive except for acyl glucuronides (AGs), which are sufficiently reactive to covalently bind to endogenous proteins. Thus, it has been suggested that AGs would contribute to IDT caused by carboxylic acid-containing drugs. Glucuronidation of a carboxylate residue is catalyzed by UDP-glucuronosyltransferase 1A and 2B isoforms. Unstable AGs undergo intramolecular rearrangements as well as non-enzymatic and enzymatic hydrolysis. The instability and reactivity toward proteins have been well studied for a large number of AGs. Moreover, the half-life of AGs in neutral buffer is becoming a common marker for the prediction of toxicity caused by carboxylic acid-containing drugs in the screening of new chemical entities; however, the underlying mechanisms of the toxicity are not elucidated. Recently, an immunostimulation assay has been proposed for the assessment of the toxicological potential of AGs, which may have a better predictability compared with half-life and peptide adduct assays. In addition to in vitro studies, studies in model animals indicate the in vivo toxicological potential of AGs and help understand the mechanisms of the AG toxicity.

摘要

特异质性药物毒性(IDT)是药物研发中的一个严重问题。反应性代谢物被认为是IDT的原因之一。除了酰基葡糖醛酸(AGs)外,共轭代谢物通常无反应性,而AGs具有足够的反应性,能够与内源性蛋白质共价结合。因此,有人提出AGs会导致含羧酸药物引起的IDT。羧酸残基的葡糖醛酸化由UDP-葡糖醛酸基转移酶1A和2B亚型催化。不稳定的AGs会发生分子内重排以及非酶促和酶促水解。对于大量的AGs,其对蛋白质的不稳定性和反应性已得到充分研究。此外,在新化学实体筛选中,AGs在中性缓冲液中的半衰期正成为预测含羧酸药物毒性的常用指标;然而,毒性的潜在机制尚未阐明。最近,有人提出了一种免疫刺激试验来评估AGs的毒理学潜力,与半衰期和肽加合物试验相比,该试验可能具有更好的预测性。除了体外研究外,在模型动物中的研究表明了AGs的体内毒理学潜力,并有助于了解AGs毒性的机制。

相似文献

1
Toxicological potential of acyl glucuronides and its assessment.酰基葡萄糖醛酸苷的毒理学潜力及其评估
Drug Metab Pharmacokinet. 2017 Feb;32(1):2-11. doi: 10.1016/j.dmpk.2016.11.002. Epub 2016 Nov 23.
2
Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays.利用半衰期、肽加合物和免疫刺激试验对酰基葡萄糖醛酸进行毒理学评估。
Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):241-9. doi: 10.1016/j.tiv.2015.10.013. Epub 2015 Oct 31.
3
Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [S]Cysteine Trapping.[S]半胱氨酸捕获法对酰基葡萄糖醛酸化物反应性和毒性的定量评价。
Chem Res Toxicol. 2019 Oct 21;32(10):1955-1964. doi: 10.1021/acs.chemrestox.9b00111. Epub 2019 Sep 20.
4
Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide.基于酰基葡萄糖醛酸苷的化学稳定性预测含羧酸类药物的特异质药物毒性风险
Drug Metab Dispos. 2010 Oct;38(10):1857-64. doi: 10.1124/dmd.110.034173. Epub 2010 Jul 6.
5
Relationship between the risk of idiosyncratic drug toxicity and formation and degradation profiles of acyl-glucuronide metabolites of nonsteroidal anti-inflammatory drugs in rat liver microsomes.非甾体抗炎药物酰基葡萄糖醛酸代谢物在大鼠肝微粒体中的形成和降解谱与药物特异质毒性风险的关系。
Eur J Pharm Sci. 2022 Jul 1;174:106193. doi: 10.1016/j.ejps.2022.106193. Epub 2022 Apr 18.
6
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.采用稳定表达人 UDP-葡糖醛酸转移酶和人肝细胞的人胚肾 293 细胞对非甾体抗炎药的酰基葡糖醛酸进行毒理学评价。
Drug Metab Dispos. 2011 Jan;39(1):54-60. doi: 10.1124/dmd.110.035600. Epub 2010 Oct 6.
7
New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.药物研发中酰基葡萄糖醛酸风险评估的新视角:体外稳定性、原位反应性及生物活化研究
Drug Metab Lett. 2018;12(2):84-92. doi: 10.2174/1872312812666180611113656.
8
Acyl glucuronide reactivity in perspective: biological consequences.酰基葡萄糖醛酸反应性透视:生物学后果
Chem Biol Interact. 2003 May 6;145(2):117-37. doi: 10.1016/s0009-2797(03)00020-6.
9
Acyl glucuronide drug metabolites: toxicological and analytical implications.酰基葡萄糖醛酸药物代谢物:毒理学及分析学意义
Ther Drug Monit. 2003 Feb;25(1):1-16. doi: 10.1097/00007691-200302000-00001.
10
NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of Ibuprofen ((+/-)-(R,S)-2-(4-isobutylphenyl) propanoic acid), its metabolites, and analogues.布洛芬((+/-)-(R,S)-2-(4-异丁基苯基)丙酸)及其代谢物和类似物的体外酰基葡萄糖醛酸迁移动力学的核磁共振光谱研究。
Anal Chem. 2007 Nov 15;79(22):8720-7. doi: 10.1021/ac071368i. Epub 2007 Oct 18.

引用本文的文献

1
Nutrient environment improves drug metabolic activity in human iPSC-derived hepatocytes and HepG2.营养环境可改善人诱导多能干细胞衍生的肝细胞和HepG2细胞中的药物代谢活性。
Arch Toxicol. 2025 Aug 12. doi: 10.1007/s00204-025-04139-4.
2
Role and Regulation of Hepatobiliary ATP-Binding Cassette Transporters during Chemical-Induced Liver Injury.化学性肝损伤中肝胆 ATP 结合盒转运蛋白的作用与调控。
Drug Metab Dispos. 2022 Oct;50(10):1376-1388. doi: 10.1124/dmd.121.000450. Epub 2022 Aug 1.
3
Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity.
旨在避免代谢活化和肝细胞毒性的新型双氯芬酸类似物的研发。
ACS Omega. 2020 Dec 8;5(50):32608-32616. doi: 10.1021/acsomega.0c04942. eCollection 2020 Dec 22.
4
Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors.人源同工型特异性尿苷二磷酸葡萄糖醛酸转移酶的变异性:急性和慢性暴露、多态性和不确定因素的标志物。
Arch Toxicol. 2020 Aug;94(8):2637-2661. doi: 10.1007/s00204-020-02765-8. Epub 2020 May 15.
5
Biotransformation Pathways and Metabolite Profiles of Oral [C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors.口服 [C]alisertib(MLN8237),一种研究中的 Aurora A 激酶抑制剂,在晚期实体瘤患者中的生物转化途径和代谢产物谱。
Drug Metab Dispos. 2020 Mar;48(3):217-229. doi: 10.1124/dmd.119.087338. Epub 2020 Jan 7.
6
Chemo-Enzymatic Synthesis, Structural and Stereochemical Characterization, and Intrinsic Degradation Kinetics of Diastereomers of 1-β--Acyl Glucuronides Derived from Racemic 2-{4-[(2-Methylprop-2-en-1-yl)amino]phenyl}propanoic Acid.外消旋2-{4-[(2-甲基丙-2-烯-1-基)氨基]苯基}丙酸衍生的1-β-酰基葡糖醛酸非对映异构体的化学酶法合成、结构和立体化学表征以及固有降解动力学
ACS Omega. 2018 May 4;3(5):4932-4940. doi: 10.1021/acsomega.8b00443. eCollection 2018 May 31.
7
New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.药物研发中酰基葡萄糖醛酸风险评估的新视角:体外稳定性、原位反应性及生物活化研究
Drug Metab Lett. 2018;12(2):84-92. doi: 10.2174/1872312812666180611113656.